This product is free for ON DPG members.
This webinar was presented live on April 13, 2023.
In this webinar, attendees will learn about cancer therapies associated with hyperglycemia and interventions. Review the process of why hyperglycemia occurs and common risk factors. Learn interventions including diet, insulin, and medication management. With an emphasis on collaborating with the multidisciplinary oncology care team. Providing up to date evidence guidelines using pathways and practical case studies.
CPE Level: 3
Performance Indicators: 6.8.1, 8.1.1, 8.2.1
- Identify cancer therapies that increase risk for hyperglycemia.
- Understand interventions to treat steroid-induced hyperglycemia.
- Determine insulin therapy necessary to treat hyperglycemia caused by parenteral/ enteral nutrition.
Makenzie Johnson, MPH, RD, CDCES, Diabetes Educator
Makenzie Johnson received her Master of Public Health in 2015 at the University of Texas Health Sciences Center in Houston and began working as a diabetes educator and dietitian in Houston, Texas. After moving to Colorado in 2016, she worked in eating disorders where she helped to develop a diabetes protocol for patients experiencing diabulemia. Makenzie has been working at the University of Colorado Health since 2020 and works closely with patients experiencing hyperglycemia related to their oncology treatment and steroid-induced hyperglycemia.
Beth Tupta, NP-C, Senior Clinical Instructor
University of Colorado Hospital
Beth Tupta started her career at UCH in 2005 in the new graduate nurse residency program on the inpatient BMT/ONC unit, and worked on this unit until 2016. Beth graduated with a Master of Science in the Adult Geriatric Nurse Practitioner Program from UC Denver in 2015, and started her career with the University of Colorado School of Medicine as a nurse practitioner in the Division of Endocrinology. She is currently a full-time clinician, dividing time between outpatient diabetes and thyroid disease management and inpatient diabetes care on the Glucose Management Team. Beth’s specialty focus has been the management of hyperglycemia in the cancer population. She has partnered with the UCH Cancer Center in developing the role of a dedicated cancer center diabetes educator and created hyperglycemia Agile Pathways to assist with timely diabetes education and hyperglycemia management in the oncology population.